Anna Ractliffe
Stock Analyst at Bank of America Securities
(2.23)
# 3,140
Out of 5,020 analysts
14
Total ratings
66.7%
Success rate
2.8%
Average return
Main Sectors:
Stocks Rated by Anna Ractliffe
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ETR: FME Fresenius Medical Care AG | Reiterated: Sell | €32.00 | €39.68 | -19.35% | 9 | Aug 3, 2026 | |
| EPA: BIM bioMérieux S.A. | Upgraded: Hold | €115.00 | €77.20 | +48.96% | 1 | Dec 12, 2025 | |
| LON: RS1 RS Group plc | Upgraded: Buy | 730p | 769p | n/a | 1 | May 13, 2025 | |
| BME: FDR Fluidra, S.A. | Upgraded: Buy | €21.00 → €26.00 | €17.19 | n/a | 2 | Apr 10, 2025 | |
| AMS: LIGHT Signify N.V. | Upgraded: Buy | €29.00 | €15.45 | n/a | 1 | Nov 6, 2024 |
Fresenius Medical Care AG
Aug 3, 2026
Reiterated: Sell
Price Target: €32.00
Current: €39.68
Upside: -19.35%
bioMérieux S.A.
Dec 12, 2025
Upgraded: Hold
Price Target: €115.00
Current: €77.20
Upside: +48.96%
RS Group plc
May 13, 2025
Upgraded: Buy
Price Target: 730p
Current: 769p
Upside: n/a
Fluidra, S.A.
Apr 10, 2025
Upgraded: Buy
Price Target: €21.00 → €26.00
Current: €17.19
Upside: n/a
Signify N.V.
Nov 6, 2024
Upgraded: Buy
Price Target: €29.00
Current: €15.45
Upside: n/a